Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Interest & Investment Income (2022 - 2025)

Historic Interest & Investment Income for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $1088.0.

  • bioAffinity Technologies' Interest & Investment Income fell 5116.7% to $1088.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7724.0, marking a year-over-year decrease of 6994.67%. This contributed to the annual value of $17610.0 for FY2024, which is 8558.11% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Interest & Investment Income stood at $1088.0, which was down 5116.7% from $2025.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Interest & Investment Income peaked at $44124.0 during Q2 2023, and registered a low of $276.0 during Q2 2022.
  • Its 4-year average for Interest & Investment Income is $13538.1, with a median of $5656.5 in 2024.
  • Per our database at Business Quant, bioAffinity Technologies' Interest & Investment Income surged by 1588695.65% in 2023 and then plummeted by 9180.67% in 2024.
  • bioAffinity Technologies' Interest & Investment Income (Quarter) stood at $38447.0 in 2022, then tumbled by 68.37% to $12160.0 in 2023, then plummeted by 66.54% to $4069.0 in 2024, then tumbled by 73.26% to $1088.0 in 2025.
  • Its last three reported values are $1088.0 in Q3 2025, $2025.0 for Q2 2025, and $542.0 during Q1 2025.